公司资料
Olink 股价、新闻与催化剂
- 股票代码:
- OLK
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
目前无法获取 OLK 的收盘价变动背景。
公司概览
业务概览
Olink was a proteomics platform company focused on high-throughput protein biomarker analysis before being acquired by Thermo Fisher Scientific.
所在地与行业分类
Headquartered in Sweden and listed in the United States before acquisition, it sat in life-sciences tools.
商业模式特征
The business was driven by proteomics instrument demand, consumables, and adoption in research and translational science.
生物医药行业定位
Olink was a premium proteomics tools name and is now best viewed through the lens of biotech infrastructure M&A.
未来催化剂
- Olink is now largely a Thermo Fisher integration and proteomics-adoption story, with catalysts tied to broader platform usage inside a much bigger life-science footprint. The stock matters mainly if protein-biomarker workflows keep scaling.
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。